In England, a familiar and uncomfortable experience, persistent heartburn, may soon lead to a different kind of first step. Draft guidance from the National Institute for Health and Care Excellence proposes that some people with lasting reflux be offered a quick sponge-on-a-thread test in their GP surgery, rather than waiting for a hospital camera examination. The aim is to catch the quiet cellular changes of Barrett's oesophagus and early oesophageal cancer while keeping the scarce capacity of hospital endoscopy for those who need it most. Yet the proposal also carries a reminder that no sing
Cancer 'Sponge on a String' Tests May Reach More Patients With Persistent Indigestion
A capsule on a thread, a tiny sponge, and minutes at the GP's surgery
So what's actually changing here? The test already exists.
It does, in some places. The draft guidance would let it be offered across England, in GP surgeries, to some people with bad, persistent indigestion.
Why does it matter where it's done?
Endoscopy is a hospital procedure with a camera, and demand for it is high. A test that takes minutes at the GP could ease that queue.
Worth saying who is claiming what. The idea that it frees up resources comes from NHS England's cancer director. It's an expectation, not a measured result in this reporting.
And the number of people involved? One to two in a hundred adults have Barrett's oesophagus?
That's the figure given, and it's phrased as what's thought. Most of those people won't develop cancer.
Right, and the piece doesn't say how many people would qualify for the test under the guidance, or how many are waiting for endoscopy now. Those numbers aren't here.
Is there a downside?
NICE itself says no test catches every case, so an all-clear doesn't end monitoring.
Also, the sponge collects cells for analysis. The reporting doesn't say how accurate it is compared with endoscopy. 'Thousands benefited' in pilots isn't an accuracy figure.
So what do we watch for?
The final NICE recommendations, due in the new year. These are still drafts.
El Pulso
- A simple capsule on a thread could soon reach patients in GP surgeries across England, sidestepping long hospital waiting lists.
- Roughly one or two in every hundred adults may carry Barrett's oesophagus, a changed lining that quietly raises cancer risk.
- NHS endoscopy demand is so strained that some people with the condition are not being checked as often as they should be.
- Pilot schemes have already helped thousands, and final NICE recommendations are due in the new year, with national rollout still being weighed.
In England, a familiar and uncomfortable experience, persistent heartburn, may soon lead to a different kind of first step. Draft guidance from the National Institute for Health and Care Excellence proposes that some people with lasting reflux be offered a quick sponge-on-a-thread test in their GP surgery, rather than waiting for a hospital camera examination. The aim is to catch the quiet cellular changes of Barrett's oesophagus and early oesophageal cancer while keeping the scarce capacity of hospital endoscopy for those who need it most. Yet the proposal also carries a reminder that no single test sees everything, so vigilance over time remains part of the bargain.
For someone living with persistent indigestion in England, the next step could soon be a visit to the GP rather than a long wait for a hospital appointment. New draft guidance from NICE proposes offering a quick "sponge in the gullet" test to some people with severe, lasting reflux. The patient swallows a small dissolving capsule on a thread. Once it reaches the stomach, it releases a sponge, which is gently drawn back up, collecting cells from the lining of the gullet along the way. The whole process takes minutes, and the cells are then analysed for signs of change.
The main target is Barrett's oesophagus, a condition that can follow years of acid reflux and raises the long-term risk of cancer. Most people who have it will never develop cancer, but the NHS cannot currently monitor everyone as often as recommended because endoscopy demand is so high. NICE says the sponge test could give more patients reassurance and help identify who needs further investigation and treatment. NHS England's national clinical director for cancer, Prof Peter Johnson, said thousands have already benefited from pilots, and that an easier check could free resources to find cancers earlier.
NICE is clear, however, that no test catches every case. A negative result still calls for long-term monitoring. These recommendations remain in draft, with final guidance expected in the new year.
A person with bad, persistent indigestion in England could soon be asked to swallow a small capsule on a thread in their GP's surgery, rather than wait for a hospital appointment. That is the proposal in new draft guidelines for the NHS in England, which recommend offering a quick "sponge in the gullet" test to some people with severe, lasting reflux to check for oesophageal cancer.
The test works in a few steps. The patient swallows a small dissolving capsule attached to a thread. Once the capsule reaches the stomach, it releases a tiny sponge. The doctor then gently pulls the thread back out through the mouth, and the sponge collects cells from the lining of the gullet on the way. Those cells are then analysed. The whole procedure can be done in minutes at a GP surgery.
It is a different proposition from the usual check, an endoscopy, which uses a small camera to look inside the body and is done in hospital. The sponge tests are already offered in some places, and the draft guidance could extend them across England.
The target is a condition called Barrett's oesophagus, which can accompany heartburn or acid reflux and raises the long-term risk of cancer. It is thought that between one and two adults in every 100 have it, meaning the cells lining the gullet have started to change. Most of those people will not go on to develop cancer. But demand for NHS endoscopy is high, and as a result some people with the condition are not being checked as often as recommended.
The National Institute for Health and Care Excellence (NICE), which issued the draft, says the sponge tests could give more patients peace of mind. Its chief executive, Prof Jonathan Benger, described them as a "quick and less invasive" way to spot concerning changes, helping to identify who should go on to further tests and treatment.
Prof Peter Johnson, national clinical director for cancer at NHS England, said thousands of people have already benefited from the test through pilots the NHS has run. He called it fantastic that national rollout is now being considered. Many people have acid reflux, he said, and an easier way to check the oesophageal lining could make a big difference to patients, cutting the need for more complicated endoscopies and freeing NHS resources to find cancers earlier.
NICE adds a caution. No diagnostic test, endoscopy included, picks up every case, so people who get an all-clear from a sponge test should still be monitored over the long term. The tests are meant to help detect both oesophageal cancer and Barrett's oesophagus in people with reflux disease.
Reflux itself causes heartburn, a burning sensation in the middle of the chest, along with an unpleasant sour taste in the mouth from stomach acid. Over time the acid can damage the oesophageal lining. A lax or weakened sphincter at the bottom of the food pipe, where it meets the stomach, can be part of the problem, letting digestive juices seep upward. Being overweight, smoking and drinking alcohol can all raise the risk.
These are draft recommendations only. NICE will publish its final recommendations in the new year.
Citas Notables
Sponge tests offer a quick and less invasive way to detect concerning changes.— Prof Jonathan Benger, chief executive of NICE (paraphrased)
Having an easier way to check for changes in the lining of the oesophagus can make a big difference for patients.— Prof Peter Johnson, national clinical director for cancer, NHS England